New bandage could slash infection risk for kids in ICU
NCT ID NCT07175116
First seen Jun 25, 2026 · Last updated Jul 14, 2026 · Updated 3 times
Summary
This study tests whether a special antimicrobial dressing can reduce bloodstream infections from central venous catheters in children in intensive care. About 250 children will be randomly assigned to receive either the antimicrobial dressing or a standard one. The main goal is to see if the special dressing lowers infection rates.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Chlorhexidine gluconate-impregnated transparent dressing
- What this could lead to
- If it works, this could provide a simple way to lower the risk of serious bloodstream infections in children with central lines.
- What could go wrong
- This is a single-center trial with 250 participants, so results may not apply everywhere. The dressing could also cause skin irritation in some children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
250 people
The number who actually took part.
- Started
-
May 2024
- Finished
-
Nov 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
2 months to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Admission to paediatric intensive care unit (PICU) * Central venous catheter placement (central or peripherally inserted) * Informed consent obtained from parent/legal guardian Exclusion Criteria: * Known immunological disorders * Neutropenia (\<500/mm³) * Pre-existing colonisation or infection with multidrug-resistant organisms
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bloodstream infection are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Universitario Virgen del Rocío - Hospital Infantil
Seville, Sevilla, 41004, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a computer model speed up sepsis blood tests?
- Can kids with blood infections skip the IV earlier?
- Can a smarter catheter cut infections and blockages?
- AI could outsmart bacteria: a smarter way to choose antibiotics?
- Could one blood draw be enough to catch dangerous infections?
- A 5-hour test may replace days of waiting for the right antibiotic in blood infections